SG Power raises authorised capital fourfold, seeks sector reclassification at PSX

SG Power Limited has increased its authorised share capital fourfold to Rs800 million and applied to the Pakistan Stock Exchange (PSX) for reclassification from the Power Generation sector to the Pharmaceuticals sector as part of its strategic transformation.

In a material information notice submitted to the PSX on Tuesday, the company said it had completed all legal and regulatory formalities, including payment of the prescribed fees, to increase its authorised share capital from Rs200 million to Rs800 million following shareholder approval.

The company said the increase in authorised capital would provide the capacity required to proceed with its proposed rights issue, subject to receiving all applicable regulatory and corporate approvals.

SG Power also informed the exchange that it had formally requested the PSX to reclassify its sector from Power Generation to Pharmaceuticals, in line with its approved strategic transformation and revised principal line of business.

The company said it would continue to keep the stock exchange and its shareholders informed of any further material developments in accordance with applicable regulatory requirements.

On June 29, 2026, SG Power announced the completion of the required corporate and regulatory formalities to change its principal line of business from Power Generation Allied (Other) to Pharmaceutical Allied (Healthcare Sector).

Under the amended principal line of business, the company is now authorised, subject to applicable laws and regulatory approvals, to import, export, manufacture, distribute, market, sell, rent, install, maintain and provide after-sales servicing of medical equipment, medical devices, hospital supplies and related healthcare products.

The revised business scope also allows the company to manufacture and trade pharmaceutical, medicinal and allied products, as set out in its amended Memorandum of Association.